- Home
- BWFG vs LRMR Comparison
BWFG vs LRMR Comparison
Compare BWFG & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWFG
- LRMR
- Stock Information
- Founded
- BWFG 2002
- LRMR N/A
- Country
- BWFG United States
- LRMR United States
- Employees
- BWFG N/A
- LRMR N/A
- Industry
- BWFG Major Banks
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- BWFG Finance
- LRMR Health Care
- Exchange
- BWFG Nasdaq
- LRMR Nasdaq
- Market Cap
- BWFG 333.1M
- LRMR 309.8M
- IPO Year
- BWFG N/A
- LRMR N/A
- Fundamental
- Price
- BWFG $43.11
- LRMR $4.82
- Analyst Decision
- BWFG Buy
- LRMR Strong Buy
- Analyst Count
- BWFG 2
- LRMR 7
- Target Price
- BWFG $42.00
- LRMR $16.71
- AVG Volume (30 Days)
- BWFG 44.5K
- LRMR 4.7M
- Earning Date
- BWFG 10-27-2025
- LRMR 10-29-2025
- Dividend Yield
- BWFG 1.86%
- LRMR N/A
- EPS Growth
- BWFG N/A
- LRMR N/A
- EPS
- BWFG 2.64
- LRMR N/A
- Revenue
- BWFG $81,749,000.00
- LRMR N/A
- Revenue This Year
- BWFG $66.56
- LRMR N/A
- Revenue Next Year
- BWFG $14.45
- LRMR N/A
- P/E Ratio
- BWFG $16.30
- LRMR N/A
- Revenue Growth
- BWFG 0.32
- LRMR N/A
- 52 Week Low
- BWFG $26.39
- LRMR $1.61
- 52 Week High
- BWFG $46.85
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- BWFG 48.66
- LRMR 57.10
- Support Level
- BWFG $43.05
- LRMR $4.52
- Resistance Level
- BWFG $44.57
- LRMR $4.99
- Average True Range (ATR)
- BWFG 0.93
- LRMR 0.52
- MACD
- BWFG -0.44
- LRMR 0.04
- Stochastic Oscillator
- BWFG 13.43
- LRMR 73.57
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.